NYSE:LCI Lannett (LCI) Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.65▼$2.5152-Week Range N/AVolume280,600 shsAverage Volume92,067 shsMarket Capitalization$7.38 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media About Lannett (NYSE:LCI) StockLannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.Read More Receive LCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter. Email Address LCI Stock News HeadlinesMay 22, 2023 | americanbankingnews.comLannett (NYSE:LCI) Now Covered by Analysts at StockNews.comMay 13, 2023 | americanbankingnews.comStockNews.com Initiates Coverage on Lannett (NYSE:LCI)June 1, 2023 | Edge On The Street (Ad)AI is Unstoppable. Now Is The Time!AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.May 1, 2023 | finance.yahoo.comLannett Company, Inc. Enters Into Restructuring Support AgreementApril 26, 2023 | americanbankingnews.comLannett (NYSE:LCI) Coverage Initiated by Analysts at StockNews.comApril 20, 2023 | finance.yahoo.comNYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSApril 10, 2023 | americanbankingnews.comLannett (NYSE:LCI) Receives New Coverage from Analysts at StockNews.comApril 4, 2023 | finance.yahoo.comLANNETT SHARES UPDATEJune 1, 2023 | Edge On The Street (Ad)AI is Unstoppable. Now Is The Time!AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.February 26, 2023 | thestreet.comWhy Lannett (LCI) Stock Is Down TodayFebruary 7, 2023 | finance.yahoo.comRecent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past yearFebruary 2, 2023 | finance.yahoo.comLannett Company, Inc. (NYSE:LCI) Q2 2023 Earnings Call TranscriptFebruary 1, 2023 | finance.yahoo.comLANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCEFebruary 1, 2023 | finance.yahoo.comLannett (LCI) Reports Q2 Loss, Tops Revenue EstimatesJanuary 25, 2023 | finance.yahoo.comLANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITJanuary 25, 2023 | finance.yahoo.comLANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1January 4, 2023 | finance.yahoo.comLANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTSNovember 9, 2022 | finance.yahoo.comLannett Company First Quarter 2023 Earnings: Revenues Beat Expectations, EPS LagsNovember 7, 2022 | finance.yahoo.comLANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAMNovember 2, 2022 | finance.yahoo.comLANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCEOctober 26, 2022 | finance.yahoo.comLANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2October 21, 2022 | finance.yahoo.comLANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANTOctober 19, 2022 | prnewswire.comLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGS - PR NewswireOctober 19, 2022 | finance.yahoo.comLANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGSOctober 15, 2022 | seekingalpha.comLCI Lannett Company, Inc.October 5, 2022 | finance.yahoo.comLannett Company, Inc. (LCI)September 28, 2022 | law360.comEx-Pharma CEO Denied 3rd Circ. Rehearing In $1M FBAR Case - Law360See More Headlines Receive LCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter. Email Address LCI Company Calendar Last Earnings11/03/2021Today6/01/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNYSE:LCI CUSIP51601210 CIK57725 Webwww.lannett.com Phone(215) 333-9000Fax215-333-9004Employees810Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($18.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-231,620,000.00 Net Margins-62.40% Pretax Margin-62.67% Return on EquityN/A Return on Assets-13.39% Debt Debt-to-Equity RatioN/A Current Ratio2.23 Quick Ratio1.39 Sales & Book Value Annual Sales$340.58 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($23.34) per share Price / BookN/AMiscellaneous Outstanding Shares10,770,000Free Float9,354,000Market Cap$7.38 million OptionableOptionable Beta0.95 Key ExecutivesTimothy C. CrewChief Executive Officer & DirectorJohn KozlowskiChief Financial Officer & Vice President-FinanceRobert EhlingerChief Information Officer & Vice PresidentMaureen M. CavanaughChief Commercial Operations Officer & Senior VPJohn M. AbtChief Quality Operations Officer & Vice PresidentKey CompetitorsCumberland PharmaceuticalsNASDAQ:CPIXBellicum PharmaceuticalsNASDAQ:BLCMGalmed PharmaceuticalsNASDAQ:GLMDAdial PharmaceuticalsNASDAQ:ADILExicureNASDAQ:XCURView All CompetitorsInsiders & InstitutionsSusquehanna International Group LLPSold 3,600 shares on 5/16/2023Ownership: 0.000%Group One Trading L.P.Sold 500 shares on 5/12/2023Ownership: 0.000%Wolverine Asset Management LLCBought 93,000 shares on 5/8/2023Ownership: 0.000%LSV Asset ManagementSold 296,539 shares on 5/2/2023Ownership: 0.871%Simplex Trading LLCSold 34,500 shares on 4/27/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions LCI Stock - Frequently Asked Questions How were Lannett's earnings last quarter? Lannett Company, Inc. (NYSE:LCI) posted its quarterly earnings data on Wednesday, November, 3rd. The company reported ($1.08) earnings per share for the quarter, missing analysts' consensus estimates of ($1.00) by $0.08. The company had revenue of $101.53 million for the quarter, compared to analysts' expectations of $98.62 million. During the same quarter last year, the business posted $0.24 EPS. When did Lannett's stock split? Lannett shares reverse split before market open on Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What is Timothy Crew's approval rating as Lannett's CEO? 9 employees have rated Lannett Chief Executive Officer Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among the company's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Lannett own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA). What is Lannett's stock symbol? Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI." Who are Lannett's major shareholders? Lannett's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Telemus Capital LLC (32.34%), Telemus Capital LLC (17.89%), Group One Trading L.P. (0.00%), Wolverine Asset Management LLC (0.00%), LSV Asset Management (0.87%) and Assenagon Asset Management S.A. (0.67%). Insiders that own company stock include David A Drabik, Jeffrey Farber, John Abt, John C Chapman, John Kozlowski, Melissa Rewolinski, Patrick G Lepore, Patrick G Lepore, Samuel H Israel and Timothy C Crew. View institutional ownership trends. How much money does Lannett make? Lannett (NYSE:LCI) has a market capitalization of $0.00 and generates $340.58 million in revenue each year. The company earns $-231,620,000.00 in net income (profit) each year or ($18.88) on an earnings per share basis. How many employees does Lannett have? The company employs 810 workers across the globe. How can I contact Lannett? Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The official website for the company is www.lannett.com. The company can be reached via phone at (215) 333-9000 or via fax at 215-333-9004. This page (NYSE:LCI) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lannett Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.